Application eBook: Increasing LC-MS accessibility for streamlined biotherapeutic analysis
2 November 2020

Mass spectrometry (MS), once a technology empowering biotherapeutic characterization, is now a fundamental part of biopharma workflows for attribute-based analysis. This attribute monitoring role has application across the breadth of product and process development, and has expanded into manufacturing and quality organizations that have traditionally had limited experience with LC-MS. 

Find out how the Waters BioAccord System provides appropriate sensitivity, mass resolution and selectivity for directly analyzing biomolecules in the form of native proteins and protein complexes, denatured proteins, peptides, nucleic acids, and labeled glycans, providing biopharmaceutical organizations with deeper insights across drug development and commercial operations.

The eBook covers the capabilities of the BioAccord LC-MS System across many biopharma-related applications, including:

  • Intact mass analysis
  • Peptide mapping
  • Oligonucleotides
  • Compliant-ready MAM workflows
  • Antibody-drug conjugates
  • AAV capsid proteins